Title |
Defining Disease, Diagnosis, and Translational Medicine within a Homeostatic Perturbation Paradigm: The National Institutes of Health Undiagnosed Diseases Program Experience
|
---|---|
Published in |
Frontiers in Medicine, May 2017
|
DOI | 10.3389/fmed.2017.00062 |
Pubmed ID | |
Authors |
Timothy Gall, Elise Valkanas, Christofer Bello, Thomas Markello, Christopher Adams, William P. Bone, Alexander J. Brandt, Jennifer M. Brazill, Lynn Carmichael, Mariska Davids, Joie Davis, Zoraida Diaz-Perez, David Draper, Jeremy Elson, Elise D. Flynn, Rena Godfrey, Catherine Groden, Cheng-Kang Hsieh, Roxanne Fischer, Gretchen A. Golas, Jessica Guzman, Yan Huang, Megan S. Kane, Elizabeth Lee, Chong Li, Amanda E. Links, Valerie Maduro, May Christine V. Malicdan, Fayeza S. Malik, Michele Nehrebecky, Joun Park, Paul Pemberton, Katherine Schaffer, Dimitre Simeonov, Murat Sincan, Damian Smedley, Zaheer Valivullah, Colleen Wahl, Nicole Washington, Lynne A. Wolfe, Karen Xu, Yi Zhu, William A. Gahl, Cynthia J. Tifft, Camillo Toro, David R. Adams, Miao He, Peter N. Robinson, Melissa A. Haendel, R. Grace Zhai, Cornelius F. Boerkoel |
Abstract |
Traditionally, the use of genomic information for personalized medical decisions relies on prior discovery and validation of genotype-phenotype associations. This approach constrains care for patients presenting with undescribed problems. The National Institutes of Health (NIH) Undiagnosed Diseases Program (UDP) hypothesized that defining disease as maladaptation to an ecological niche allows delineation of a logical framework to diagnose and evaluate such patients. Herein, we present the philosophical bases, methodologies, and processes implemented by the NIH UDP. The NIH UDP incorporated use of the Human Phenotype Ontology, developed a genomic alignment strategy cognizant of parental genotypes, pursued agnostic biochemical analyses, implemented functional validation, and established virtual villages of global experts. This systematic approach provided a foundation for the diagnostic or non-diagnostic answers provided to patients and serves as a paradigm for scalable translational research. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 17 | 49% |
Australia | 2 | 6% |
United Kingdom | 1 | 3% |
New Zealand | 1 | 3% |
Spain | 1 | 3% |
Switzerland | 1 | 3% |
Japan | 1 | 3% |
Unknown | 11 | 31% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 22 | 63% |
Scientists | 11 | 31% |
Science communicators (journalists, bloggers, editors) | 1 | 3% |
Practitioners (doctors, other healthcare professionals) | 1 | 3% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 41 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 8 | 20% |
Student > Master | 7 | 17% |
Other | 4 | 10% |
Professor | 2 | 5% |
Student > Bachelor | 2 | 5% |
Other | 8 | 20% |
Unknown | 10 | 24% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 8 | 20% |
Biochemistry, Genetics and Molecular Biology | 7 | 17% |
Engineering | 3 | 7% |
Nursing and Health Professions | 2 | 5% |
Agricultural and Biological Sciences | 1 | 2% |
Other | 6 | 15% |
Unknown | 14 | 34% |